Health News (Reuters)

Medtronic misses revenue estimates, shares dip

(Reuters) - Medical device maker Medtronic Plc on Tuesday reported quarterly revenue fell short of analysts' estimates, hurt by lower sales in its diabetes-related device business.

Philip Morris International CEO cheers U.S. FDA tobacco proposal

(Reuters) - The chief executive of Philip Morris International said he was "extremely encouraged" by the U.S. Food and Drug Administration's recent proposal to lower nicotine levels in cigarettes and nudge smokers toward less harmful alternatives such as e-cigarettes.

American surgeons poorly prepared for humanitarian operations

(Reuters Health) - A Haitian physician taught American-trained vascular surgeon Dr. David Kuwayama how to perform C-sections in a Caribbean clinic, and a Congolese surgeon taught him other basic surgical procedures in an African war zone.

J&J ordered to pay $417 million in trial over talc cancer risks

(Reuters) - A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene.

Shire's CFO resigns to join plant technology start-up

LONDON (Reuters) - Pharmaceutical company Shire said its chief financial officer Jeff Poulton will stand down at the end of the year to join Indigo Ag, a Boston-based start-up that seeks to improve agricultural productivity.

Britain's Creo receives speedy FDA approval for its endoscopic device

LONDON (Reuters) - Britain's Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch.

AstraZeneca ups investment in messenger RNA drugs with Ethris deal

FRANKFURT (Reuters) - AstraZeneca has stepped up its investment in messenger RNA drugs, a promising approach in genetic therapy, by spending more than 25 million euros ($29 million) on a research alliance with German biotech start-up Ethris.

In health push, Singapore gets soda makers to cut sugar content

SINGAPORE (Reuters) - Singapore's prime minister has urged people to drink water, eat wholemeal bread and choose brown rice over white in a health push that began with an agreement from soda makers to reduce the sugar content in drinks sold in the country.

New Novartis drug takes aim at tough-to-treat malaria

LONDON (Reuters) - Novartis is taking aim at drug-resistant malaria – a growing global problem – by launching clinical trials of the first new antimalarial medicine for many years in nine countries across Africa and Asia.

U.S. study revives argument over mammogram screening

(Reuters Health) - Yearly mammograms starting at age 40 would prevent the most deaths from breast cancer, U.S. researchers reported on Monday in a challenge to more conservative recommendations that take into account both the harms and the benefits of screening.

Bayer, J&J win third U.S. trial over Xarelto bleeding risk

(Reuters) - A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers' blood thinner Xarelto led to severe internal bleeding.

Spouse hostility may worsen chronic low back pain

(Reuters Health) - People with chronic low back pain may feel it even more sharply if their spouses are critical and unsupportive of their condition, according to a recent study.

Pages